Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas
- 10 November 2004
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 204 (5), 546-554
- https://doi.org/10.1002/path.1662
Abstract
Hepatoblastoma (HB) is the most frequent malignant liver tumour of childhood. Most HBs develop sporadically but their incidence is highly elevated in patients with familial adenomatous polyposis coli (FAP). These patients carry germline mutations in the adenomatous polyposis coli (APC) tumour suppressor gene. APC forms a multi-protein complex involved in the WNT signalling pathway that controls the stability of β-catenin, the central effector in this cascade. Whereas APC mutations are rare in sporadic HBs, a high frequency of β-catenin mutations leading to overactivation of WNT signalling was previously found in these tumours. This pathway is negatively controlled by conductin (axin2), representing a further partner in this signalling complex. To investigate whether alterations in conductin may also be involved in the pathogenesis of sporadic HBs, 37 HBs and five HB cell lines were screened for mutations using single-strand conformation polymorphism (SSCP) analysis, reverse transcription-polymerase chain reaction (RT-PCR), and direct sequencing. In two cases, larger deletions (52 and 1624 bp) leading to frameshifts were found. In addition, one HB carried a somatic point mutation. Expression analysis by competitive RT-PCR in HBs revealed up-regulation of conductin mRNA compared with adjacent liver samples. This mRNA overexpression resulted in increased conductin protein levels demonstrated by western blot analysis. Tumours with activating β-catenin mutations revealed higher levels of conductin mRNA transcripts. This finding indicates that conductin is a direct target gene of WNT signalling in HBs, as has been demonstrated in other tissues. In summary, conductin mutations may represent an alternative mechanism leading to activation of WNT signalling in HBs. The overexpression of conductin mRNA in HBs reflects activation of the WNT pathway because conductin represents a target gene of WNT signalling in liver tissue. Copyright © 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell–immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotypeBlood, 2007
- Activation of AXIN2 Expression by β-Catenin-T Cell FactorJournal of Biological Chemistry, 2002
- Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signallingNature Genetics, 2000
- Wnt/β-Catenin Signaling Induces the Expression and Activity of βTrCP Ubiquitin Ligase ReceptorMolecular Cell, 2000
- Activation of β-catenin in epithelial and mesenchymal hepatoblastomasOncogene, 2000
- Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathwaysOncogene, 1999
- Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3βCurrent Biology, 1998
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Molecular analysis of the lissencephaly gene 1 (LIS‐1) in medulloblastomasNeuropathology and Applied Neurobiology, 1996
- Risk of hepatoblastoma in familial adenomatous polyposisAmerican Journal of Medical Genetics, 1992